Effects of ovariectomy and estrogen replacement on aorta angiotensin-converting enzyme activity in rats

Japanese Journal of Pharmacology

Volumn 73, Issue 4, 1997, Pages 361-363

  Tanaka, Masami ^a   Nakaya, Sachiko ^a   Watanabe, Minoru ^a   Kumai, Toshio ^a   Tateishi, Tomonori ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme (ACE); Aorta; Estrogen replacement therapy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ESTRADIOL; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; NONHUMAN; OVARIECTOMY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030979898     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.73.361     Document Type: Article

References (15)

1. Farmer JA and Gotto AM Jr: Current and future therapeutic approaches to hyperlipidemia. Adv Pharmacol 35, 79-114 (1996)
2. Keaney JF Jr, Shwaery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL and Vita JA: 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 89, 2251-2259 (1994)
3. Chobanian AV, HaudCenschild CC, Nickerson C and Drago R: Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 156, 327-331 (1990)
4. Schuh JR, Blehm DJ, Frierdich EG, McMahon EG and Blaine EH: Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 91, 1453-1458 (1993)
5. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F and Alhenc-Gelas F: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90, 669-676 (1994)
6. Keidar S, Kaplan M, Shapira C, Brook JG and Aviram M: Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis 107, 71-84 (1994)
7. Keidar S, Kaplan M and Aviram M: Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Arterioscler Thromb Vase Biol 16, 97-105 (1996)
8. Dzau VJ: Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77, Supp I4-I13 (1988)
9. Smith MS, Freeman ME and Neill JD: The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rats: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 96, 219-226 (1975)
10. Miyazaki M, Okunishi H, Nishimura K and Toda N: Vascular angiotensin-converting enzyme activity in man and other species. Clin Sci 66, 39-45 (1984)
11. Seltzer A, Pinto JEB, Viglione PN, Correa FMA, Libertun C, Tsutsumi K, Steele MK and Saavedra JM: Estrogens regulate, angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology 55, 460-467 (1992)
12. Verma ND and Panda JN: Effect of estrogen on angiotensin converting enzyme in immature quail oviduct. Indian J Exp Biol 30, 650-652 (1992)
13. Bayard F, Clamens S, Delsol G, Blaes N, Maret A and Faye JC: Oestrogen synthesis, oestrogen metabolism and functional oestrogen receptors in bovine aortic endothelial cells. Ciba Found Symp 191, 122-138 (1995)
14. Fischer GM and Swain ML: Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis 54, 177-185 (1985)
15. Haarbo J: Hormone replacement therapy and cardiovascular disease: the rabbit model. Br J Obstet Gynaecol 103, Supp 13, 49-52 (1996)